Revised SPCs: Glensoludex (dexamethasone) soluble tablets (all strengths)

This is now licensed for the treatment of COVID-19 in adult and adolescent patients (aged 12 years and older with body weight at least 40 kg) who require supplemental oxygen therapy. Related posology and administration and clinical trial data have been added.

electronic Medicines compendium